Use of the BioMedicus centrifugal pump in traumatic tears of the thoracic aorta.
Traumatic blunt thoracic aortic injury is a clinical entity of increasing incidence. After the diagnosis of traumatic tear of the aorta is made, there is some controversy over whether the aorta should be repaired using cardiopulmonary bypass, a heparinized shunt, or cross-clamping and graft interposition without a shunt or bypass. At Allegheny General Hospital, 19 patients were treated for traumatic tears of the thoracic aorta between July 1, 1977, and June 30, 1983. They can be divided into two groups: Group 1 (July 1, 1977, through October 31, 1981), in which no shunt or bypass or only a heparinized shunt was used, and Group 2 (November 1, 1981, through June 30, 1983), in which left atrium-femoral artery bypass was performed using a BioMedicus heparinless pump and tubing. Among the 10 patients in Group 1, 4 died and 2 had paraplegia postoperatively. Among the 9 patients in Group 2, 1 died and none experienced paraplegia following operation. We believe that the BioMedicus centrifugal pump is a simple, safe means of perfusing the lower body, kidneys, and spinal column without necessitating heparinization in a patient with multiple injuries or the placement of a cumbersome heparinized shunt. Because of the simplicity and the reliability demonstrated, this pump should be considered for use in all patients with traumatic tears of the thoracic aorta.
D000293:Adolescent; D000328:Adult; D001013:Aorta, Thoracic / Q000293:injuries*; D002315:Cardiopulmonary Bypass / Q000295:instrumentation*; D002404:Catheterization; D003250:Constriction; D005263:Femoral Artery / Q000601:surgery; D006325:Heart Atria / Q000601:surgery; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged
D006493:Heparin